Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.stemcr.2019.12.003
Title: | Enhancing the Efficacy of Stem Cell Therapy with Glycosaminoglycans | Authors: | Ling, L. Ren, X. Cao, X. Hassan, A.B.M. Mah, S. Sathiyanathan, P. Smith, R.A.A. Tan, C.L.L. Eio, M. Samsonraj, R.M. van Wijnen, A.J. Raghunath, M. Nurcombe, V. Hui, J.H. Cool, S.M. |
Keywords: | cartilage repair efficacy ex vivo expansion FGF2 heparan sulfate osteochondral regeneration potency stemness |
Issue Date: | 2020 | Publisher: | Cell Press | Citation: | Ling, L., Ren, X., Cao, X., Hassan, A.B.M., Mah, S., Sathiyanathan, P., Smith, R.A.A., Tan, C.L.L., Eio, M., Samsonraj, R.M., van Wijnen, A.J., Raghunath, M., Nurcombe, V., Hui, J.H., Cool, S.M. (2020). Enhancing the Efficacy of Stem Cell Therapy with Glycosaminoglycans. Stem Cell Reports 14 (1) : 105-121. ScholarBank@NUS Repository. https://doi.org/10.1016/j.stemcr.2019.12.003 | Rights: | Attribution-NonCommercial-NoDerivatives 4.0 International | Abstract: | Human mesenchymal stem cell (hMSC) therapy offers significant potential for osteochondral regeneration. Such applications require their ex vivo expansion in media frequently supplemented with fibroblast growth factor 2 (FGF2). Particular heparan sulfate (HS) fractions stabilize FGF2-FGF receptor complexes. We show that an FGF2-binding HS variant (HS8) accelerates the expansion of freshly isolated bone marrow hMSCs without compromising their naivety. Importantly, the repair of osteochondral defects in both rats and pigs is improved after treatment with HS8-supplemented hMSCs (MSCHS8), when assessed histologically, biomechanically, or by MRI. Thus, supplementing hMSC culture media with an HS variant that targets endogenously produced FGF2 allows the elimination of exogenous growth factors that may adversely affect their therapeutic potency. © 2019 The AuthorsThis study highlights a novel strategy to improve cartilage repair using hMSCs cultured with heparan sulfates that target and stabilize fibroblast growth factor 2. The work is focused on developing bio-additives that prevent the loss of hMSCs stemness during their ex vivo expansion that is important for maintaining their therapeutic utility. © 2019 The Authors | Source Title: | Stem Cell Reports | URI: | https://scholarbank.nus.edu.sg/handle/10635/196214 | ISSN: | 2213-6711 | DOI: | 10.1016/j.stemcr.2019.12.003 | Rights: | Attribution-NonCommercial-NoDerivatives 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1016_j_stemcr_2019_12_003.pdf | 5.4 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License